Use of docetaxel in combination with octreotide as a synergistic combination for prostate cancer with apoptotic and antiangiogenic effects

KARACA Ş. B., ATMACA H., bozkurt e., sezgin c., KARABULUT B., USLU F. R.

2014 ASCO Annual Meeting, 30 May - 03 June 2014

• Publication Type: Conference Paper
• Manisa Celal Bayar University Affiliated: Yes